Related Experiment Video
Updated: Feb 21, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Metabolic Status and Hypogonadism in Human Immunodeficiency Virus-infected Males
Sarita Bajaj1, Yashaswi Pathak1, Sharad Varma2
1Department of Medicine, Motilal Nehru Medical College, Allahabad, Uttar Pradesh, India.
Insights
Hypogonadism is more common in human immunodeficiency virus (HIV)-infected males. This condition is linked to age, CD4 count, and highly active antiretroviral therapy (HAART) duration, but not BMI or metabolic status.
Area of Science:
- Endocrinology
- Infectious Diseases
- Virology
Background:
- Human immunodeficiency virus (HIV) infection can impact endocrine function.
- Hypogonadism, a condition of reduced testosterone production, is a potential complication in HIV-infected individuals.
Purpose of the Study:
- To determine the prevalence of hypogonadism in HIV-infected males.
- To investigate the association between hypogonadism and factors like age, CD4 count, BMI, HAART duration, and metabolic status.
Main Methods:
- A case-control study involving 81 HIV-positive males and 82 healthy controls.
- Assessment included physical examination, serum glucose, A1c, lipid profile, total testosterone (TT), FSH, and LH levels.
- Hypogonadism was defined by TT levels and/or compensatory hormonal markers and correlated with clinical and metabolic parameters.
Main Results:
- The prevalence of hypogonadism was significantly higher in HIV-infected males (25.9%) compared to controls (4.9%).
- Hypogonadism was significantly associated with older age, lower CD4 count, and longer duration of HAART.
- No significant association was found between hypogonadism and BMI, waist circumference, dyslipidemia, or dysglycemia.
Conclusions:
- HIV-infected males exhibit a higher prevalence of hypogonadism than healthy individuals.
- Age, CD4 count, and HAART duration are significant factors associated with hypogonadism in this population.
- Hypogonadism in HIV-infected males is independent of BMI and metabolic disturbances like dyslipidemia and dysglycemia.
Aims And Objectives:
The aim of this study is to determine the prevalence of hypogonadism in human immunodeficiency virus (HIV)-infected males and to study its relation to age, CD4 count, body mass index (BMI), duration of highly active antiretroviral therapy (HAART), and metabolic status.
Methodology:
Eighty-one HIV positive cases and 82 healthy controls were included in this case-control study. Each case underwent a complete physical examination and serum fasting plasma glucose, A1c, lipid profile, total testosterone (TT), follicle-stimulating hormone (FSH), and luteinizing hormone (LH) levels were estimated. Serum TT level <300 ng/dl, or TT >300 ng/dl with high LH and FSH (compensatory hypogonadism) were taken as markers for hypogonadism, and it was correlated with age, CD4 count, duration of HAART, and metabolic status of the patient.
Results:
Out of 81 cases, 21 (25.9%) were found to have hypogonadism as compared to 4 (4.9%) out of 82 controls. Of these 21, 14 cases had secondary hypogonadism, five had primary, and the remaining two had compensatory hypogonadism. The mean serum TT value among cases (371.7 ± 102.9 ng/dl) was significantly lower than that among controls (419.7 ± 71.5 ng/dl) (P = 0.007). Hypogonadism was found to be significantly associated with the age of the patient (P = 0.007), CD4 count (P = 0.002), and duration of HAART (P = 0.04) and was independent of the BMI (P = 0.9) and the waist circumference (P = 0.8). Dyslipidemia and dysglycemia were significantly more common among cases as compared to controls (P < 0.05) but were not associated with hypogonadism.
Conclusion:
The prevalence of hypogonadism is higher among HIV-infected males as compared to healthy individuals. Hypogonadism was significantly associated with age, CD4 count, and duration of HAART and was independent of BMI, glycemic status, and dyslipidemia.
More Related Videos
06:28A Simple Flow Cytometric Method to Measure Glucose Uptake and Glucose Transporter Expression for Monocyte Subpopulations in Whole Blood
Published on: August 12, 2016
09:54Chronic, Acute, and Reactivated HIV Infection in Humanized Immunodeficient Mouse Models
Published on: December 3, 2019
Related Concept Videos
Sexually Transmitted Infections
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Infertility in Males